pillbase.ru

Sylvant

Active substance: siltuximab

siltuximab

Centralised EU authorisationActive

Marketing holder: Recordati Netherlands B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Sylvant
    INJECTION, POWDER, FOR SOLUTION · SILTUXIMAB 100 mg/1
    73090-420
    Recordati Rare Diseases, Inc.
  • Sylvant
    INJECTION, POWDER, FOR SOLUTION · SILTUXIMAB 400 mg/1
    73090-421
    Recordati Rare Diseases, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12097-4edd-7f6e-a0f3-584fec3ef4a1,01a12099-dd8e-7b39-8692-b368f8fb4de9;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/003708
Registration status
Active
ATC code
L04AC11
Sources
  • product · EMA · EMEA/H/C/003708 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/003708 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/003708 · Verified 2026-10-09